| FORM 3 | UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
| |||||||||||||||
1. Name and Address of Reporting Person*
(Street)
| 2. Date of Event Requiring Statement (Month/Day/Year) 12/02/2019 | 3. Issuer Name and Ticker or Trading Symbol EXELON CORP [ EXC ] | |||||||||||||
| 4. Relationship of Reporting Person(s) to Issuer (Check all applicable)
| 5. If Amendment, Date of Original Filed (Month/Day/Year) | ||||||||||||||
6. Individual or Joint/Group Filing (Check Applicable Line)
| |||||||||||||||
| Table I - Non-Derivative Securities Beneficially Owned | |||
|---|---|---|---|
| 1. Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
| Common Stock | 11,008 | D | |
| Common Stock (401k shares) | 644 | I | By Exelon Employee Savings Plan (401k plan) |
| Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||
|---|---|---|---|---|---|---|---|
| 1. Title of Derivative Security (Instr. 4) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) | ||
| Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
| Restricted Stock Unit Award (01/30/2017) | (1) | (1) | Common stock | 1,278 | (1) | D | |
| Restricted Stock Unit Award (01/29/2018) | (2) | (2) | Common stock | 2,257 | (2) | D | |
| Restricted Stock Unit Award (02/04/2019) | (3) | (3) | Common stock | 2,652 | (3) | D | |
| Deferred Compensation Equivalent Shares | (4) | (4) | Common stock | 639 | (4) | D | |
| Explanation of Responses: |
| 1. Remaining 1/3 increment of annual restricted stock unit (RSU) award granted in 2017 pursuant to the Exelon Long Term Incentive Plan; each award vests in 1/3 increments on the date of the Compensation & Leadership Development Committee's January meeting in the first, second and third years after the award was granted. Award balances accrue addtional units through automatic dividend reinvestment, which vest on the same schedule as the underlying award. |
| 2. Remaining 2/3 increment of annual RSU award granted in January 2018 pursuant to the Exelon Long Term Incentive Plan; each award vests in 1/3 increments on the date of the Compensation & Leadership Development Committee's January meeting in the first, second and third years after the award was granted. Award balances accrue addtional units through automatic dividend reinvestment, which vest on the same schedule as the underlying award. |
| 3. Annual RSU award granted in February 2019 pursuant to the Exelon Long Term Incentive Plan; each award vests in 1/3 increments on the date of the Compensation & Leadership Development Committee's January meeting in the first, second and third years after the award was granted. Award balances accrue addtional units through automatic dividend reinvestment, which vest on the same schedule as the underlying award. |
| 4. Phantom share equivalents representing units held in the Exelon stock fund in a multi-fund, non-qualified deferred compensation plan. The Exelon stock fund is a unitized fund that consists of Exelon common stock and short term investments. Units of the fund will be settled upon the reporting person's termination of service for any reason. Units will be settled in cash. Units are acquired through regular periodic contributions, company matching contributions and the reinvestment of dividend equivalents. The balance of phantom share equivalents may fluctuate from time to time due to fluctuations in the fund composition. |
| Remarks: |
| Elizabeth M. Hensen, Attorney-in-Fact for Carim V. Khouzami | 12/11/2019 | |
| ** Signature of Reporting Person | Date | |
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
| * If the form is filed by more than one reporting person, see Instruction 5 (b)(v). | ||
| ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
| Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. | ||
